Healthcare provider profile · identity verified

Rochelle Rutter, CNP

Nurse Practitioner · ZANESVILLE, OH · NPI 1861652208

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	578	122
Potassium Chloride	Potassium Chloride	484	88
Atorvastatin Calcium	Atorvastatin Calcium	425	83
Tramadol Hcl	Tramadol Hcl	380	69
Oxycodone Hcl	Oxycodone Hcl	318	59
Levothyroxine Sodium	Levothyroxine Sodium	312	59
Alprazolam	Alprazolam	285	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	283	50
Mirtazapine	Mirtazapine	281	63
Metoprolol Succinate	Metoprolol Succinate	270	54
Trazodone Hcl	Trazodone Hcl	237	52
Gabapentin	Gabapentin	233	53
Pantoprazole Sodium	Pantoprazole Sodium	226	68
Eliquis	Apixaban	221	42
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	215	38
Lorazepam	Lorazepam	193	38
Metoprolol Tartrate	Metoprolol Tartrate	193	39
Lisinopril	Lisinopril	184	38
Famotidine	Famotidine	173	34
Divalproex Sodium	Divalproex Sodium	167	36
Hydralazine Hcl	Hydralazine Hcl	161	21
Tamsulosin Hcl	Tamsulosin Hcl	161	31
Amlodipine Besylate	Amlodipine Besylate	153	31
Sertraline Hcl	Sertraline Hcl	153	39
Prednisone	Prednisone	140	69
Warfarin Sodium	Warfarin Sodium	135	16
Carvedilol	Carvedilol	130	32
Pregabalin	Pregabalin	128	17
Metformin Hcl	Metformin Hcl	124	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	123	31
Hydroxyzine Hcl	Hydroxyzine Hcl	115	41
Torsemide	Torsemide	94	20
Baclofen	Baclofen	93	25
Duloxetine Hcl	Duloxetine Hcl	92	22
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	91	58
Hydroxyzine Pamoate	Hydroxyzine Pamoate	90	29
Fluticasone Propionate	Fluticasone Propionate	84	35
Citalopram Hbr	Citalopram Hydrobromide	83	18
Ondansetron Hcl	Ondansetron Hcl	83	27
Lactulose	Lactulose	75	19
Buspirone Hcl	Buspirone Hcl	73	15
Clopidogrel	Clopidogrel Bisulfate	72	17
Carbidopa-Levodopa	Carbidopa/Levodopa	70	13
Allopurinol	Allopurinol	69	18
Doxycycline Hyclate	Doxycycline Hyclate	67	51
Xarelto	Rivaroxaban	67	suppressed
Nystatin	Nystatin	65	44
Ondansetron Odt	Ondansetron	65	37
Clonazepam	Clonazepam	64	13
Escitalopram Oxalate	Escitalopram Oxalate	64	16
Clonidine Hcl	Clonidine Hcl	63	11
Donepezil Hcl	Donepezil Hcl	63	13
Lamotrigine	Lamotrigine	63	suppressed
Jardiance	Empagliflozin	62	12
Losartan Potassium	Losartan Potassium	60	16
Fluvoxamine Maleate	Fluvoxamine Maleate	53	suppressed
Omeprazole	Omeprazole	51	14
Farxiga	Dapagliflozin Propanediol	50	suppressed
Spironolactone	Spironolactone	50	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	13
Promethazine Hcl	Promethazine Hcl	49	23
Fluconazole	Fluconazole	46	36
Oxybutynin Chloride Er	Oxybutynin Chloride	45	suppressed
Sucralfate	Sucralfate	45	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	29
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	11
Ezetimibe	Ezetimibe	43	12
Hydrochlorothiazide	Hydrochlorothiazide	43	suppressed
Methadone Hcl	Methadone Hcl	43	suppressed
Finasteride	Finasteride	42	suppressed
Phenobarbital	Phenobarbital	41	suppressed
Tresiba Flextouch U-200	Insulin Degludec	40	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	29
Levofloxacin	Levofloxacin	35	31
Cimetidine	Cimetidine	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Ozempic	Semaglutide	34	suppressed
Trulicity	Dulaglutide	34	12
Cholestyramine	Cholestyramine (With Sugar)	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Meclizine Hcl	Meclizine Hcl	32	suppressed
Memantine Hcl	Memantine Hcl	32	14
Simvastatin	Simvastatin	32	suppressed
Bupropion Xl	Bupropion Hcl	30	11
Lokelma	Sodium Zirconium Cyclosilicate	30	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	30	20
Entresto	Sacubitril/Valsartan	28	suppressed
Incruse Ellipta	Umeclidinium Bromide	28	suppressed
Nyamyc	Nystatin	28	15
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Albuterol Sulfate	Albuterol Sulfate	27	19
Alendronate Sodium	Alendronate Sodium	27	suppressed
Glipizide	Glipizide	27	suppressed
Atenolol	Atenolol	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	19
Brilinta	Ticagrelor	25	suppressed
Fiasp	Insulin Aspart (Niacinamide)	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	13
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Olanzapine	Olanzapine	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Risperidone	Risperidone	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Ketoconazole	Ketoconazole	24	15
Rosuvastatin Calcium	Rosuvastatin Calcium	24	suppressed
Gemtesa	Vibegron	23	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Benztropine Mesylate	Benztropine Mesylate	22	suppressed
Elmiron	Pentosan Polysulfate Sodium	22	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	22	suppressed
Clonidine	Clonidine	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Tresiba	Insulin Degludec	21	suppressed
Azithromycin	Azithromycin	20	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Scopolamine	Scopolamine	20	suppressed
Morphine Sulfate	Morphine Sulfate	19	13
Rivastigmine	Rivastigmine	19	suppressed
Sodium Chloride	0.9 % Sodium Chloride	19	11
Diazepam	Diazepam	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Erythromycin	Erythromycin Base	16	suppressed
Novolin R	Insulin Regular, Human	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Cephalexin	Cephalexin	15	12
Colchicine	Colchicine	15	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Ibuprofen	Ibuprofen	14	12
Lacosamide	Lacosamide	14	suppressed
Prevalite	Cholestyramine	14	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Loperamide	Loperamide Hcl	13	11
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Linzess	Linaclotide	12	suppressed
Meropenem	Meropenem	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Cefepime Hcl	Cefepime Hcl	11	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Metformin Er Osmotic	Metformin Hcl	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error